Completed from United Kingdom
Wow! This course was a game‑changer for my career. I signed up hoping to sharpen my skills in health‑technology assessment, and the depth of the content blew me away. The module on sensitivity analysis gave me the confidence to run probabilistic models, and I immediately applied that knowledge to a cost‑utility analysis for a new diabetes medication at my firm. The resources – from the up‑to‑date journal articles to the downloadable Excel templates – were top‑notch. My overall experience was enthusiastic and rewarding; I now feel ready to lead pharmacoeconomic projects.
The Master Certificate in Undergraduate Certificate in Pharmacoeconomics exceeded my expectations. The course content directly aligned with my goal to understand cost‑effectiveness analysis for new therapies. I was able to calculate incremental cost‑effectiveness ratios (ICERs) using real‑world data from a case study on an oncology drug, which I later applied in my workplace to support formulary decisions. The lecture slides were clear, the recommended readings were up‑to‑date, and the interactive Excel models helped me develop practical budgeting skills. Overall, the learning experience was professional and highly relevant, and I feel fully equipped to contribute to health‑technology assessments.
I really enjoyed the way the course was set up – it felt like a chill mix of video lessons and hands‑on assignments. I wanted to get a grip on basic pharmacoeconomic concepts, and the modules on quality‑adjusted life years (QALYs) and budget impact analysis gave me exactly that. One cool thing was the group project where we built a simple model for a vaccine rollout, which I actually used in a volunteer role with a local health board. The materials were spot‑on, and the instructor was quick to answer questions. All in all, a solid, satisfying learning ride.
The curriculum was meticulously designed, covering everything from basic health economics terminology to advanced decision‑analytic modelling. My primary learning goal was to master the construction of Markov models, and the detailed step‑by‑step tutorials, along with the real‑world case study on hepatitis treatment, made this possible. I especially appreciated the supplemental reading list, which included recent WHO guidelines and peer‑reviewed articles. The course platform was user‑friendly, and the weekly live Q&A sessions helped clarify complex concepts. In sum, a thorough and satisfying educational experience.
